Alice French

1 month ago | thestar.com.my | Mia Glass |Alice French

JAPAN’s sovereign debt market is flashing a warning to the central bank that dialing back its bond purchases needs to be done with great care. The issue is in sharp relief this week, with investors shunning an auction of government debt and yields soaring, just as market participants sit down with Bank of Japan (BoJ) officials to share views on tapering. Already a subscriber? Log in. Subscribe now and receive free sooka plan for 1 month. T&C applies.

1 month ago | bloomberglinea.com | Mia Glass |Alice French |Toru Hanai

Bloomberg — El mercado de deuda soberana de Japón está lanzando una advertencia al banco central de que la reducción de sus compras de bonos debe hacerse con mucho cuidado. La cuestión se ha puesto de relieve esta semana, con los inversores rehuyendo una subasta de deuda pública y los rendimientos disparándose, justo cuando los participantes en el mercado se sientan con funcionarios del Banco de Japón para compartir opiniones sobre el tapering.

1 month ago | bloomberg.com | Mia Glass |Alice French

(Bloomberg) -- Japan’s sovereign debt market is flashing a warning to the central bank that dialing back its bond purchases needs to be done with great care. The issue is in sharp relief this week, with investors shunning an auction of government debt and yields soaring, just as market participants sit down with Bank of Japan officials to share views on tapering.

1 month ago | news.bloombergtax.com | Alice French |Aya Wagatsuma

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

1 month ago | bloomberglinea.com | Alice French |Kanoko Matsuyama |Lisa Pham |Simon Dawson

Bloomberg — Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, anunciara su intención de ordenar una reducción de los costos de los medicamentos recetados en EE.UU. para equipararlos a los de otros países. Esto generó preocupación sobre el impacto en las ganancias del sector. Farmacéuticas europeas, entre ellas Novo Nordisk A/S (NVO), AstraZeneca Plc (AZN) y Roche Holding AG, se desplomaron.